0.48
Schlusskurs vom Vortag:
$0.4261
Offen:
$0.43
24-Stunden-Volumen:
1.05M
Relative Volume:
0.18
Marktkapitalisierung:
$14.22M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.58M
KGV:
-0.4174
EPS:
-1.15
Netto-Cashflow:
$-9.80M
1W Leistung:
+10.70%
1M Leistung:
-12.73%
6M Leistung:
-43.40%
1J Leistung:
-79.31%
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Firmenname
Acurx Pharmaceuticals Inc
Sektor
Branche
Telefon
917-533-1469
Adresse
259 LIBERTY AVENUE, STATEN ISLAND
Vergleichen Sie ACXP mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ACXP
Acurx Pharmaceuticals Inc
|
0.48 | 12.75M | 0 | -14.58M | -9.80M | -1.15 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Acurx Pharmaceuticals Inc Aktie (ACXP) Neueste Nachrichten
What drives Acurx Pharmaceuticals Inc. stock priceBreakthrough stock performance - jammulinksnews.com
What analysts say about Acurx Pharmaceuticals Inc. stockSuperior return velocity - jammulinksnews.com
Is Acurx Pharmaceuticals Inc. a good long term investmentAccelerated wealth expansion - jammulinksnews.com
Acurx Pharmaceuticals Inc. Stock Analysis and ForecastSignificant capital appreciation - jammulinksnews.com
How Acurx Pharmaceuticals Inc. stock performs during market volatility3x Return Stock Radar - Newser
What risks could impact Acurx Pharmaceuticals Inc. stock performanceFree Stock Market Analysis Courses - Newser
Acurx Pharmaceuticals Holds Annual Meeting and Elections - TipRanks
Acurx Pharmaceuticals shareholders approve board proposals at annual meeting - Investing.com Australia
Acurx Pharmaceuticals shareholders approve board proposals at annual meeting By Investing.com - Investing.com South Africa
Acurx Pharmaceuticals files $50M mixed shelf offering - MSN
Acurx Files to Sell 9.16M Shares of Common Stock for Holders - AInvest
What makes Acurx Pharmaceuticals Inc. stock price move sharplyFree Exclusive Group - Newser
Why Acurx Pharmaceuticals Inc. stock attracts strong analyst attentionExplosive Growth Potential - Newser
Acurx Pharmaceuticals (NASDAQ:ACXP) Stock Price Up 3.6% – Here’s Why - Defense World
ACXP SEC FilingsAcurx Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ACXP raises $2.3M via warrant inducement, issues 9.1M new warrants - Stock Titan
Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year? - Yahoo Finance
Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Investors Purchase Large Volume of Acurx Pharmaceuticals Call Options (NASDAQ:ACXP) - Defense World
Acurx Pharmaceuticals Raises Fresh $2.67M Capital: New Antibiotic Development Gets Major Funding Boost - Stock Titan
/C O R R E C T I O N -- Acurx Pharmaceuticals, Inc./ - Yahoo Finance
Acurx Pharmaceuticals Inc (ACXP) Stock: The Story of a 52-Week Stock Range - investchronicle.com
Crude Oil Rises Sharply; Jabil Earnings Top Views - Benzinga
US Stocks Lower; Retail Sales Decline In May - Benzinga
Power Metallic (TSX.V: PNPN) Secures Largest Saudi License Amid June 2025 Gold Surge – Material Gains & More Stocks Inside - FinancialContent
Acurx Pharmaceuticals Soars as Breakthrough Antibiotic Data Hits the Headlines - RagingBull
Banco Santander S.A. ADR Inc. (SAN) Price Performance: A Comparative Analysis with Competitors - investchronicle.com
Why Is Acurx Pharmaceuticals Stock (ACXP) Up 250% Today? - TipRanks
Breakthrough: New Antibiotic Achieves 94% Cure Rate Against C. Difficile, Outperforms Standard Treatment - Stock Titan
(PDF) A unique inhibitor conformation selectively targets the DNA polymerase PolC of Gram-positive priority pathogens - researchgate.net
Mirum Pharmaceuticals Expands Team with 10 New Hires, Grants $5.7M Stock Options Package - Stock Titan
TJX Maintains Strong Dividend Program: Top Retail Chain Announces $0.425 Per Share Payout - Stock Titan
Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):